Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by CytoAgents, Inc.
CytoAgents Expands Scientific Advisory Board Appointing Dr. Michael Wechsler and Dr. Johann Gudjonsson to Guide Pipeline Expansion
May 20, 2026
From
CytoAgents, Inc.
Via
Business Wire
CytoAgents Appoints Dr. Johannes Wolff as Chief Medical Officer and Michael Howell as Chief Scientific Officer
December 16, 2025
From
CytoAgents, Inc.
Via
Business Wire
CytoAgents to Present New CTO1681 Data at the ESMO Immuno-Oncology Congress 2025
December 09, 2025
From
CytoAgents, Inc.
Via
Business Wire
CytoAgents Announces Poster Presentation of New CTO1681 Clinical Data at the 67th American Society of Hematology Annual Meeting
December 02, 2025
From
CytoAgents, Inc.
Via
Business Wire
CytoAgents Receives Fourth Grant From National Institutes of Health to Advance Research on Cytokine Release Syndrome
October 01, 2025
From
CytoAgents, Inc.
Via
Business Wire
CytoAgents Announces Appointment of New Chief Medical Officer
September 07, 2022
From
CytoAgents, Inc.
Via
Business Wire
CytoAgents’ Phase 1 Trial Results Show “Cytokine Release Syndrome” Drug Candidate Safe
August 10, 2021
From
CytoAgents, Inc.
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.